On the one hand, studies revealing an impact of IDH1 mutation on VTE suggested that this genetic event may drive methylation-mediated down regulation of two procoagulant effectors, TF and PDPN in cancer cells (6, 60, 91). This evidence concerns the gene IDH1 and cancer.